Stem cell treatment for multiple sclerosis trial#
The name of the trial is “ Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis“. We published results from our phase 1/2 clinical trial in the March, 2018 edition of the Journal of Translational Medicine. Currently, the University of Cambridge is conducting formal clinical studies using mesenchymal stem cells for treatment of MS. Mesenchymal stem cells may also potentially help remyelination (re-generation of the myelin sheath) of the affected neurons. Mesenchymal stem cells (MSCs), have immune regulatory properties which may stop the immune system from attacking the myelin sheath. While these approaches are useful for reducing the severity of disease, they do not repair the damage to nervous system tissue that has already occurred and therefore they cannot cure multiple sclerosis. Current approaches, such as interferon, copaxone, or immune suppressants all act in a nonspecific manner blocking immune responses against the myelin sheath. Golden Cells™ – Cell Selection Process at Medistem PanamaĬan stem cells help treat multiple sclerosis?Īt present there are no FDA-approved treatments that specifically target the abnormal immune responses in MS.The Wild West of Stem Cells in the United States – Roberta Shapiro, DO, FAAPM&R.
Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (hUC-MSCs) for Autism and Multiple Sclerosis – Christian Diaz MD.Regenerative Medicine the Future of Interventional Orthopedics – Rudy Herrera, MD.Stem Cells: Their Role in Aging and in the Treatment of Chronic Diseases – Neil Riordan PA, PhD.Joe Rogan Interview with Mel Gibson and Dr.Medistem Panama – Adult Stem Cell Laboratory.
0 kommentar(er)
